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CHAPTER I
INTRODUCTION
Dynamic all out high-intensity anaerobic exercise quickly leads to fatigue and a
decrease in muscle force output. As a result, an athlete’s performance output would, over
time, decrease accordingly. In response, Stevens, Godfrey, Kaminski, and Braith (2000)
developed a new supplement combining ketoacid/amino acid metabolic treatment that
became known as Glycine-Arginine-Alpha-Ketoisocaproic Acid Calcium (GAKIC).
Specifically, GAKIC contains glycine, arginine, and ketoisocaproic acid. Glycine
is a nonessential amino acid that is used for muscle biosynthesis (Chyun & Griminger,
1984). Furthermore, arginine is an essential amino acid that helps the body process both
creatine and nitrogen. Creatine and nitrogen are two substances that are used during
normal muscle metabolism (Camic, Housh, Zuniga, Hendrix, Mielke, Johnson, &
Schmidt, 2010; Hambrecht, Hilbrich, Erbs, Gielen, Fiehn, Schoene, & Schuler, 2000;
Zajac, Poprzecki, Zebrowska, Chalimoniuk, & Langfort, 2010). Lastly, ketoisocaproic
acid functions as a precursor for the essential amino acid leucine (Anthony, J., Anthony,
T, & Layman, 2010). Ketoisocaproic acid is an important precursor because leucine is
used to stimulate protein synthesis in muscle and is closely related to the release of
gluconeogenic precursors (Coburn, Housh, D, Housh, T, Malek, Beck, Cramer, Johnson,
& Donlin, 2006; Mero, 1999; Mero, Leikas, Knuutinen, Hulmi, & Kovanen, 2009). This
amino acid combination was postulated to improve dynamic performance of skeletal
muscle during acute, anaerobic, exhaustive dynamic exercise in healthy individuals.
1

Stevens et al. (2000) reported that GAKIC ingestion increased muscle torque and
work during intense acute anaerobic dynamic exercise. Specifically, GAKIC increased
overall muscular performance by delaying muscle fatigue during the early stages of
anaerobic dynamic exercise (Stevens et al, 2000). Several mechanisms are proposed to
enhance performance including alterations in acidosis, clearance of ammonia and
transamination waste products, and alterations in the enzymatic pathways concerning
nitrogen and branched chain ketoacid metabolism (Buford, & Koch, 2004). Stevens et al.
(1998) theorized the following: 1) GAKIC treatment may increase the ability to sustain
athletic muscle force during intense anaerobic muscle exercise; 2) GAKIC treatment may
also increase the ability to sustain athletic muscle work during intense anaerobic muscle
exercise; and 3) GAKIC may further increase the overall muscle performance by
decreasing absolute muscle fatigue while retarding the rate of muscle fatigue. However,
to date, the exact mechanisms for GAKIC are still unknown.
According to Beis et al. (2011), the amino acids that make up GAKIC seem to be
active in certain metabolic pathways. These metabolic pathways are associated with the
biosynthesis of creatine, protein, and nitric oxide. GAKIC’s effects may also be linked to
stabilizing muscle pH or a reduction of ammonia concentration that is released from the
purine nucleotide cycle. This possibly occurs through the alterations in the enzymatic
pathways of nitrogen metabolism.
To date, there have only been three published studies investigating the effects of
GAKIC supplementation on exercise performance (Stevens et al, 1998; Buford, & Koch,
2004; Beis, Mohammad, Easton, & Pitsiladis, 2011).The studies were all performed on
either cycling or an isokinetic dynamometer and used only male participants. Stevens et
2

al. (2000) and Buford and Koch (2004) both used untrained males for their study. Both
Stevens et al. and Buford and Koch reported positive effects for participants using
GAKIC supplementation in their studies. In contrast, Beis et al. reported no significant
differences in exercise performance for trained males on GAKIC supplementation. The
conflicting results could be related to the different training status of the participants
selected, the experimental design, and the methodology employed. None of the studies
cited above used weight exercises or tested female participants. Therefore, the purpose of
this study was to determine the ergogenic effects of GAKIC ingestion on resistance
training performance in both trained male and female participants.

Statement of Problem
Little research has been done investigating the ability of GAKIC to enhance
performance during a traditional resistance exercise protocol. While studies have
demonstrated improvements in performance during high-intensity exercise, no research
has examined whether an acute ingestion of GAKIC prior to resistance exercise can
enhance the performance of trained male and female participants engaged in that
exercise.
Hypotheses (Experiment 1 and 2)
HO1: There is no significant difference in blood lactate (BLa) between GAKIC and
placebo (PL) treatments in male participants.
HO2: There is no significant difference in heart rate (HR) between GAKIC and PL
treatments in male participants.
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HO3: There is no significant difference in total load at 75% of 1RM for five sets between
GAKIC and PL treatments in male participants.
HO₄: There is no significant difference in blood glucose between GAKIC and PL
treatments in male participants.
HO₅: There is no significant difference in blood lactate (BLa) between GAKIC and
placebo (PL) treatments in female participants.
HO₆: There is no significant difference in heart rate (HR) between GAKIC and PL
treatments in female participants.
HO₇: There is no significant difference in 1RM between GAKIC and PL treatments in
female participants.
HO₈: There is no significant difference in total load at 50% of 1RM for six sets between
GAKIC and PL treatments in female participants.

Basic Assumptions
The following are basic assumptions for this study:
1. Measurements made on all equipment were accurately performed.
2. The participants did not consume any food for two hours prior to testing.
3. The participants understood the directions given to them.
4. The participants followed the directions given to them.
5. The participants abstained from intense exercise for 48 hours preceding each trial.
6. The participants did not consume any nonprescription medications or
supplementation in the 48 hours prior to each trial.
7. The participants performed the exercise to failure.
4

8. The participants accurately recorded their diet and exercise recall for the 24 hours
prior to testing.
9. The participants were non- anabolic steroid using individuals.

Limitations
The following are limitations of the study:
1. The investigators did not test the individuals for anabolic or exogenous steroid
use.
2. Due to each participant monitoring his own food intake for 24 hours prior to
testing, nutritional intake was neither exactly accurate nor duplicated.
3. Due to blood lactate being obtained from the finger tip, measurements may not
accurately reflect what was occurring in the muscles.
4. The investigators did not analyze the supplement for purity of sample.

Delimitations
The following are delimitations of the study:
1. The participants were college students between the age of 18 and 40.
2. The participants were recreationally trained lifters (> six months of lifting
experience).

Definitions
1. Failure: inability to complete a repetition without assistance.
2. Fatigue: a reduction in work capacity resulting from preceding work.
5

3. Maximal Strength: The maximal amount of weight an individual can lift one time.

Significance of the Study
Little research has been done investigating the effects of supplemental GAKIC
ingestion on performance during a traditional resistance exercise protocol. While studies
have demonstrated improvements in performance during high-intensity cycling exercise,
no research has been conducted using traditional resistance exercise. Therefore, this study
contributes information regarding GAKIC’s effects during a traditional resistance
protocol to the current body of scientific knowledge.
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CHAPTER II
REVIEW OF LITERATURE
The following section will provide an overview of the basic energy systems,
muscle contraction, fiber types, muscular strength, muscular endurance, and GAKIC.
This will provide insight into the basic energy requirements needed for movement and
lay the basic foundation, using information from the current literature, regarding GAKIC
ingestion.
ATP-PC System
Muscular exercise requires a continuous supply of adenosine triphosphate (ATP)
in order to provide enough energy to produce a contraction (Tullson & Terjung, 1991).
ATP is an important compound because it couples the energy that is released from the
breakdown of food into a form of energy that is usable and needed by all cells. Because
muscle cells store only a limited amount of available ATP, metabolic pathways exist in
the cells to supply additional energy. These pathways must have the ability to produce
ATP at a rapid rate. Therefore, an individual’s muscle cells have the capability to produce
ATP by using one or a combination of three metabolic pathways. The three metabolic
pathways include the following: 1) formation of ATP by phosphocreatine (PC)
breakdown, 2) formation of ATP through the degradation of glucose or glycogen in a
process known as glycolysis, and 3) oxidative formation of ATP. Because glycolysis and
the PC pathway do not involve the use of oxygen, these methods of ATP formation are
known as anaerobic pathways (Powers & Howley, 2007).
7

In anaerobic ATP production, ATP production involves the donation of a
phosphate group and its bond energy from a combination of PC to ADP to form ATP
(Bessman & Carpender, 1985; Conley, 1994; DeZwaan & Thillard, 1985; Holloszy,
1982; Whipp & Mahler, 1980). However, the body’s muscle cells do not store large
amounts of PC. As a result, the amount of ATP formation through this reaction for
energy use is limited. Therefore, the body uses a combination of stored ATP and PC
known as the ATP-PC system (phosphagen system). The ATP-PC system provides the
energy needed for muscular contraction at the start of exercise and during short-term,
high-intensity exercise. The reformation of PC requires ATP (Cerretelli, Rennie, &
Pendergast, 1980; di Prampero, Boutellier, & Pietsch, 1983). However, this only occurs
during the recovery periods after exercise. The ATP-PC system is important for athletes
who participate in short term, intense exercise because the exercises only require a few
seconds to complete. In such activities, a rapid supply of ATP is required. As a result, the
ATP-PC system provides a simple one-enzyme reaction to produce the ATP needed for
these activities (Powers & Howley, 2007).

Anaerobic Glycolysis
Another method of anaerobic ATP production is known as glycolysis. In
glycolytic reactions, two end products are created, pyruvic acid and hydrogen atoms
combined with NAD+ to form NADH and H+. If either or both of these build up to
excessive amounts, the glycolytic process is halted. Therefore, no further formation of
ATP would take place. When this occurs, the two end products react with each other to
form what is known as lactic acid (Guyton & Hall, 2006). As exercise intensity increases,
a greater flow of excess hydrogen to pyruvate is produced causing the concentration of
8

lactate to quickly rise within the active muscle. During recovery, the excess hydrogen in
the lactate oxidizes to result in the reformation of a pyruvate molecule (McArdle, Katch,
& Katch, 2009). The enzyme, lactate dehydrogenase (LDH), catalyzes this reaction
resulting in the formation of lactic acid and the reformation of nicotinamide adenine
dinucleotide (NAD). Therefore, the formation of lactic acid is used for the reprocessing
of NAD in order for glycolysis to continue (Armstrong, 1979; Johnson, 1987). Glycolysis
is an important mean of releasing energy from the glucose molecule. It is the process of
splitting the glucose molecule to form two molecules of pyruvic acid. Because it does not
require oxygen in the chemical reaction for the breakdown of glucose into pyruvic acid,
glycolysis is considered an anaerobic process (Guyton & Hall, 2006).
Intense exercise can possibly cause muscular performance to be weakened during
both the acute and chronic phases of the exercise. Dynamic high-intensity anaerobic use
of skeletal muscle can quickly lead to fatigue and a decrease in muscle force and work.
As a result, an athlete’s performance is reduced. Many ergogenic supplements have been
used in an attempt to enhance muscle performance during acute and long-term exercise.
However, most of these attempts have resulted in limited success.
Aerobic Glycolysis
Glycolysis is known as the anaerobic production of ATP. It is our body’s pathway
for producing ATP without oxygen. However, glycolysis has also been considered to be
the first step in the aerobic degradation of carbohydrates, which in turn aids in Aerobic
ATP Production. The Krebs cycle becomes the next stage in the process of the
degradation of the glucose molecule to form ATP (Guyton & Hall, 2006). This process
occurs in the mitochondria of the cell. The Krebs cycle is used to degrade the acetyl-CoA
9

substrate to carbon dioxide and hydrogen atoms. When the hydrogen atoms are oxidized
during the electron transport-oxidative phosphorylation, the formation of ATP occurs.
Oxygen is not directly used during the Krebs cycle reactions. However, within the
pyruvate, the chemical energy transfers to ADP through the electron transport-oxidative
phosphorylation. With adequate oxygen, enzymes, and substrate, NAD+ and FAD
regenerate allowing the Krebs cycle to continue (McArdle, Katch, F., & Katch, V., 2010).
The process of aerobic ATP production is a three stage process. In stage 1, a vital twocarbon molecule is created known as acetyl-CoA. In stage 2, the oxidation of the
molecule acetyl-CoA occurs in the Krebs cycle. In stage 3, the process of oxidative
phosphorylation (ATP formation) in the electron transport chain occurs (Powers &
Howley, 2007).
Muscle Contraction
Muscular contraction can be described as a complex process that involves a
number of cellular proteins and energy production systems. Muscle contraction occurs
through the sliding filament mechanism. The actin filaments being pulled completely
inward with the myosin filaments results in their ends becoming overlapped to maximum
extension. As a result, forces are generated by the interaction of the cross-bridges from
the myosin filaments with the actin filaments (Guyton & Hall, 2006). The actin filaments
are activated by calcium ions. Once activated, the heads of the cross-bridges from the
myosin filaments become attracted to the actin filaments’ active sites. The heads of the
cross-bridges from the myosin filaments bend back and forth pulling the ends of the actin
filaments toward the center of the myosin filament causing a contraction (Metzger, 1992;
Rayment et al., 1992; Ruegg, 1992; Vale, 1994).
10

Muscle Fibers
Muscle fibers, irrespective of gender, are divided into two categories: slow twitch
and fast twitch (Buchthal & Schmalbruch, 1970; Burke, 1986; Edgerton et al., 1983;
Edgerton et al., 1986; MacIntosh, Gardiner, & McComas, 2005). Fiber type percentage
found within the skeletal muscle can be influenced by many factors including: genetics,
blood levels of hormones, and the exercise habits of the individual. Further, there are no
noticeable differences in fiber type distribution with sex and age (Powers & Howley,
2007). Slow twitch fibers can also be called slow-oxidative or type I fibers. Type I fibers
have four distinctive characteristics. They are the following: 1.) Low myosin ATPase
activity, 2.) Slow calcium handling ability and shortening speed, 3.) Less well-developed
glycolytic capacity than fast twitch fibers, and 4.) Large and numerous mitochondria.
They produce energy for the resynthesis of ATP mostly through the aerobic system for
the transfer of energy. The characteristics of Type I fibers cause them to be highly
resistant to fatigue. Therefore, Type I muscle fibers are best used for prolonged aerobic
exercises (McArdle, Katch, F., & Katch, V., 2010).
Fast twitch fibers can be subdivided into two categories: type IIx and type IIa.
Type IIx can also be called fast-glycolytic fibers. They have a comparatively small
number of mitochondria, less resistance to fatigue than slow twitch fibers, and a limited
capacity for aerobic metabolism (Green, 1986; Pette & Spamer, 1986). On the other
hand, type IIx fibers are high in glycolytic enzymes. These enzymes provide the type IIx
fibers with a large anaerobic capacity (Pette, 1980). Also, type IIx fibers have higher
myosin ATPase activity than any other fiber types. As a result, they have the highest
Vmax. Because type IIx fibers have very high ATPase activity, it causes them to be less
efficient and results in greater energy expenditure per unit of work performed (Powers &
11

Howley, 2007). Type IIa fast twitch muscle fibers show fast shortening speed and a
moderately well-developed capacity to transfer energy from two sources, aerobic and
anaerobic. Fast twitch muscle fibers are mostly utilized in anaerobic-type sprint activities
and other forceful muscle actions. In other words, any actions that rely almost completely
on anaerobic energy metabolism require a greater amount of fast twitch fibers (McArdle,
Katch, F., & Katch, V., 2010).
Muscular Strength
Muscular strength is an essential component when assessing an individual’s
athletic performance. In order to develop strength, exercises of high-resistance, lowrepetition using larger muscle masses to increase the maximal force production by a
muscle or muscle group are necessary (Judge & Burke, 2010). An individual’s ability to
adapt to increasing training loads requires adequate knowledge and understanding of the
volume and intensity of the different exercises. Also, another important aspect to consider
is the appropriate amount of recovery time between training periods. If there is an
inappropriate amount of recovery time, the postexercise fatigue could have an impact on
maximal force production by a muscle. Therefore, postexercise fatigue could limit the
effectiveness of the resistance training program (Judge & Burke, 2010).
When comparing absolute muscular strength in untrained men and women, it can
be found that men are generally stronger. The greatest strength difference is most often
found in the upper body, where men are nearly 50% stronger than women. In the lower
body, men are only 30% stronger than women (Morrow & Hosler, 1981). However, this
apparent strength difference between men and women is disregarded when force
production is compared on the basis of the cross-sectional area of the muscle. Human
12

muscle, regardless of whether male or female, can produce 3 to 4 kg of force per cm² of
muscle cross-section (Ikai & Fukunaga, 1968).
Muscular Endurance
Muscular endurance is the body’s way of efficiently postponing the onset of
muscular fatigue. Endurance depends greatly on the nutritional support for the muscle.
The main source of energy depends on the amount of glycogen that has been stored
within the muscles before the start of any period of exercise (Guyton & Hall, 2006).
Despite an abundant supply of oxygen to the muscles and an almost indefinite supply of
energy to the muscles through the body’s stored fat, fatigue occurs when the exercise
continues past the limits of the liver and muscle glycogen stores (McArdle, Katch, F., &
Katch, V., 2010). In order to comprehend muscular endurance, three metabolic systems
are especially important in understanding the limits of physical activity. These three
metabolic systems are (1) the phosphocreatine-creatine system, (2) the glycogen-lactic
acid system, and (3) the aerobic system. However, it is imperative that it is understood
that in order to make a contraction, the initial source of energy that is needed comes from
adenosine triphosphate (ATP). For all training levels of individuals, the amount of ATP
that is present in the muscles can only sustain about 3 seconds at maximal power output
(McArdle, Katch, F., & Katch, V., 2010). The phosphocreatine-creatine system provides
maximal power output for 8 to 10 seconds and is mainly used for maximal short bursts on
muscular power. The glycogen-lactic acid system is also said to be anaerobic metabolism.
The initial stage of this system is called glycolysis, which occurs without the use of
oxygen. During glycolysis, glucose molecules are split into two pyruvic acid molecules.
The energy that is released from the glucose molecules being split then forms ATP
13

molecules. In the second stage of the glycogen-lactic acid system, there is not a sufficient
supply of oxygen for glucose metabolism to occur. Therefore, most of the pyruvic acid is
converted into lactic acid. Because of this conversion to lactic acid, great amounts of
ATP are formed completely without the utilization of oxygen. The glycogen-lactic acid
system can provide 1.3 to 1.6 minutes of maximal muscle activity. The aerobic system is
the oxidation of glucose, fatty acids, and amino acids from the foodstuffs in the
mitochondria. The foodstuffs combine with oxygen to release great amounts of energy.
This energy is used to convert AMP and ADP into ATP. The aerobic system provides
unlimited amounts of muscular activity, as long as the nutrients stored in the body last
(McArdle, Katch, F., & Katch, V., 2010).
GAKIC
Researchers, Stevens et al. (2000), created a new supplement combining glycine
and L-arginine monohydrochloride salt of alphaketoisocaproic acid calcium. This
ketoacid/amino acid combination metabolic treatment was hypothesized to improve
dynamic performance of skeletal muscle during acute, anaerobic, exhaustive dynamic
exercise in healthy adult males compared to the control isocaloric sucrose treatment. In
their study, the effects of the treatments were assessed using the researchers’ Fatigue
Resistance Index (FRI). This supplement became known as GAKIC (Stevens, Godfrey,
Kaminski, & Braith, 2000). The results showed that compared with isocaloric
carbohydrate, the oral GAKIC treatment increased muscle torque and work continued
during intense acute anaerobic dynamic exercise. Also, GAKIC increased overall
muscular performance because it delayed the muscle fatigue during the early stages of
anaerobic dynamic exercise (Stevens, Godfrey, Kaminski, & Braith, 2000).
14

In order to maintain muscular power during short-term and high-intensity
exercise, dietary supplements have been used. Some such supplements include the
following: creatine monohydrate and beta-hydroxy-beta-methylbutyrate (HMB). These
supplements have been shown to provide the muscles with an ergogenic effect during
high-intensity exercise (Buford & Koch, 2004). Researchers, Buford and Koch (2004),
conducted a study using the supplement glycine-arginine-alpha-ketoisocaproic acid
(GAKIC). The purpose of the study was to determine the different effects that GAKIC
supplementation could have on an individual’s repeated bouts of anaerobic cycling
performance. When observing a significant treatment to time interaction, the study
resulted in a change in mean power output over the repeated sprints between the GAKIC
and placebo treatments (Buford & Koch, 2004). The researchers concluded that the data
did support an ergogenic effect of GAKIC for reducing the decline in mean power during
repeated bouts of supramaximal exercise (Buford & Koch, 2004). Further, speculation
about the ergogenic effects of GAKIC are as follows: 1) increases the ability to sustain
athletic muscle force during intense anaerobic muscle exercise; 2) increases the ability to
sustain athletic muscle work during intense anaerobic muscle exercise; and 3) increases
the overall muscle performance by decreasing muscle absolute fatigue while retarding the
rate of muscle fatigue (Stevens, Godfrey, Kaminski, & Braith, 1998).
Researchers, Beis, Mohammad, Easton, and Pitsiladis (2011) also conducted a
study using GAKIC supplementation. The purpose of their study was to investigate the
effects of GAKIC on fatigue during a series of 10 sprints in trained cyclists. The
researchers used an experimental design that was almost identical to the design used in
Buford and Koch’s study. It was hypothesized that the GAKIC supplementation would
15

enhance peak power output and reduce the decline in power output during repeated
sprints in trained cyclists. When reviewing the two conditions, the study resulted in no
significant difference between the GAKIC and PL conditions for any of the measured
performance variables. The researchers concluded that the data from their study did not
support the findings of previous studies that GAKIC will enhance high-intensity exercise
performance. Further, with this study using well-trained participants, there appears to be
very little evidence to support that GAKIC supplementation has any ergogenic effects
during high-intensity exercise performance (Beis, Mohammad, Easton, & Pitsiladis,
2011).
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CHAPTER III
METHODOLOGY
Participants
Seven apparently healthy, resistance trained adult males and nine healthy,
resistance trained females ranging in age from 18 to 36 years were recruited for this
investigation. To qualify, the participants were required to have a minimum of six months
of continuous recreational resistance exercise training. Participants were free of any
medical condition which might hinder their ability to perform the exercise protocol. Prior
to acceptance into the investigation, participants were required to complete a medical
history form (see Appendix A), to be screened for qualifying schedule conflicts, and to
sign a statement of informed consent (see Appendix B). Participants were free of any
anabolic steroid use for one year prior to participation in the investigation. The
procedures and forms in this investigation were reviewed and approved by the
Institutional Review Board at Mississippi State University (Appendix C).
Experimental Design
Treatment order (GAKIC or PL) was randomly assigned to participants. A
double-blind crossover design was used, as neither the primary investigators nor the
participants were aware of the treatment order. Sessions were separated by a minimum
of 7 days but no longer than 14 days to minimize participant fatigue in each experimental
protocol. Despite common misconceptions, this design was appropriate for females, as
oral contraceptives (Nichols, Hetzler, Villanueva, Stickley, & Kimura, 2008) and
17

menstrual cycle conditions (Miskec, Potteiger, Nau, & Zebas, 1997) do not
physiologically affect anaerobic performance.
Pretest Evaluation (Session 1)
During the initial session participants were given a thorough explanation of the
informed consent and research protocol. The informed consent was signed prior to any
evaluations of the participants. On this day all anthropometric measurements were
determined. Participants’ standing height, body mass, and percent body fat were initially
assessed. Standing height and body mass were assessed using a height/weight scale
(Healthometer 402EXP). Participants removed their shoes and stood erect with their
hands down at their side in an erect position. Heels were placed together. The
measurement stick was placed at the center of the participants head on the highest point.
Participants were weighed in shorts without shirt or shoes. Body mass was measured in
kilograms. Percent body fat was measured using the BOD POD (BOD POD, Life
Measurement, Inc., Concord, CA). Participants were asked to wear compression shorts
and compression shirts for females in order to minimize air resistance within the BOD
POD. The participants’ percent body fat was then analyzed by the BOD POD.
Experimental Protocol 1 (Session 2 & 3)
Each male participant performed the sessions a minimum of one week apart, in
which the experimental treatments, GAKIC or a PL, were randomly assigned and
administered in a double blind fashion. Upon arriving at the Sanderson Center weight
room the participants were taken to a designated area for 5 minutes of quiet rest. Next,
the participant’s heart rate (HR) and resting blood lactate levels (BLa) were measured.
HR was assessed using an automated machine (SunTech Medical Cycle). BLa was
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assessed by taking a drop of blood (5 microL or approximately 2mm diameter drops)
from the finger tip of the participant and immediately analyzed using the Lactate Pro
Analyzer (LT 1710). Results were yielded in 60 seconds or less. Immediately following
BLa assessment the participant was given GAKIC or PL, which was followed by a 40
minute rest period. Following this period, participants warmed up on a commercial
upright stationary bike for 5 minutes. Participants then completed a warm-up set on the
standard leg press. Participants used a weight of 200 pounds for 8-12 repetitions
depending on strength level. Two minutes of rest was allotted between warm-up sets.
One repetition maximum (1RM) was determined by increasing weight in 20 to 40 pound
increments depending on the participant’s strength level. One repetition maximum was
obtained in 3-6 sets. One repetition maximum represents the maximum weight lifted
once with proper form. Immediately following 1RM determination, the amount of 75%
of 1RM was placed on the leg press, while participants rested for 3 minutes. Immediately
following the recovery period, the participant completed 5 sets doing as many repetitions
as possible until failure occurred. Failure was defined as the inability to complete a full
repetition without assistance. Participants rested 3 minutes between each set. This
procedure was repeated for a total of 5 sets. HR and BLa were assessed within 5 seconds
of the final repetition during set 5. Total load volume (TLV) was calculated by
multiplying the 75% of 1RM mass lifted by the sum of repetitions to failure. Each session
was estimated to last approximately one hour and 30 minutes. Seven days later, the
participants returned to the Sanderson Center weight room and completed the identical
protocol using the other treatment.
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Experimental Protocol 2 (Session 2 & 3)
Each female participant performed the sessions a minimum of one week apart, in
which the experimental treatments, GAKIC or a PL, were randomly assigned and
administered in a double blind fashion. Upon arriving at the Exercise Physiology
Laboratory, the participants were taken to a designated area for 5 minutes of quiet rest.
Next, the participant’s heart rate (HR) and resting blood lactate levels (BLa) were
measured. HR was assessed using an automated machine (SunTech Medical Cycle).
BLa was assessed by taking a drop of blood (5 microL or approximately 2mm diameter
drops) from the finger tip of the participant and immediately analyzed using the Lactate
Pro Analyzer (LT 1710). Results were yielded in 60 seconds or less. Immediately
following BLa assessment the participant was given GAKIC or PL, which was followed
by a 40 minute rest period. Next, participants warmed up on an upright stationary bike for
five minutes. Following this general warm-up, participants performed fifteen repetitions
of two sets on the leg extensions with a mass of 11 kg. Then, in order to determine each
participant’s 1RM, a trained technician determined a beginning resistance for each
participant to perform their session. The 1RM was then determined by increasing mass in
4.5 to 9 kg increments relative to the participant’s ability to lift the first mass. The 1RM
was obtained in three to six sets. Importantly, the accepted 1RM was defined as the
ability of the participant to complete a full repetition without assistance. Following a five
minute rest period, 50% of 1RM was placed on the leg extension machine and each
participant completed as many repetitions as possible until failure occurred. Failure was
defined as the inability to complete a full repetition without assistance. This was followed
by a three minute rest, and then participants performed another set on the leg extension
machine by using the same mass. This procedure was repeated for a total of six sets.
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Total load volume was calculated by multiplying the 50% of 1RM mass lifted by the sum
of repetitions to failure. Seven days later, the participants returned to the Exercise
Physiology Laboratory and completed the identical protocol using the other treatment.
Dietary and Supplement Intake
Participants completed a 24 hour diet and exercise recall during the 40 minute
inactive period at each experimental session. They were also restricted from taking any
medication or supplementation during the 48 hours prior to each session. Participants
were also asked to abstain from intense exercise in the 48 hours preceding each session.
Participants who failed to meet this standard, which was determined approximately 8 to
10 hours prior to reporting for their session (questioned during the courtesy call the night
before), were rescheduled. Rescheduling was dependent on washout period and testing
schedule. No dietary analysis was performed.
Treatment Ingestion
Over-the-counter GAKIC (manufactured by Muscle Technology; see Appendix
D) or a cellulose based PL (Apotheca Company Inc., Woodbine, IA) were provided to
participants 40 minutes pre-exercise. GAKIC ingestion was 10.2 grams taken in pill
form. Prior studies have used a similar dose in powder form (Stevens, Godfrey,
Kaminski, & Braith, 2000). A minimum of seven days later, participants ingested the
other treatment, and repeated the identical exercise protocol. There have been no reported
side effects of GAKIC when taken in amounts recommended by the manufacturer or
cited in prior literature.
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Statistical Analysis
All statistical analyses were performed by using the GraphPad Prism (GraphPad
Software, Inc., La Jolla, CA). Data for total load volume between GAKIC and PL were
analyzed using repeated measures t-test. Data for blood lactic acid, blood glucose, and
heart rate were analyzed by using a 2 (condition; GAKIC or PL) x 2 (time; pre or post)
repeated measures analysis of variance (ANOVA). When the main effects of the 2 x 2
ANOVA were found to be significant (p < 0.05), a repeated measures t-test was
performed to identify statistical differences between groups. Significance was established
at p < 0.05. Data are reported as mean ± standard deviation.
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CHAPTER IV
RESULTS
Experimental Protocol 1
Participants
This study consisted of seven apparently healthy, resistance trained male
participants. A sample size analysis was performed and showed that participants were
required to achieve a power of 0.80. The intra-class correlations were > 0.80.
Table 1

Male Participant Characteristics (mean + SD)
Age (y)

Height (m)

Body mass (kg)

Body fat (%)

20.7 ± 1.3

1.78 ± 0.07

89.8 ± 12.5

19.7 ± 7.9

Total Load Volume
Total load volume was calculated by multiplying the 75% of the 1RM mass by the
total number (i.e. sum of five sets) of repetitions to failure. Our data showed a significant
(p < 0.05) increase in TLV after GAKIC supplementation. Specifically, GAKIC’s TLV
was 31564 ± 9132 kg, whereas the PL TLV was 25763 ± 6595 kg. (Figure 1)
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Figurre 1

Tottal Load Vollume (1)

Loweer body muscular enduraance was dettermined by calculating tthe total loadd volume
(TLV
V = 75% of one
o repetition
n maximum mass lifted X the sum oof repetitionss to failure).
The data
d points for
fo each partiicipant are sh
hown in the graphs. * inndicates p < 0.05 betweeen
GAK
KIC and PL.
Hearrt Rate
Heart ratee was measured as an ind
dicator of exxercise intenssity and to ddocument thaat
particcipants in bo
oth groups ex
xerted similaar effort folloowing GAK
KIC and PL
suppllementation. At rest (pree), there weree no differennces for hearrt rate betweeen GAKIC
(64.6
6 ± 7.6 beats per minute (bpm))
(
and PL
P (63.2 ± 66.6 bpm) (p > 0.05). Folllowing the
exerccise protocoll, heart rate increased
i
sig
gnificantly inn both groupps (GAKIC = 142.4 ±
15.5 bpm;
b
PL = 140.7
1
± 9.5 bpm;
b
p < 0.0
05 comparedd to pre) but iit was not diifferent (p >
0.05)) between gro
oups. (Figurre 2)
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Figurre 2

Heart Rate (1)

Heartt rate (beats per minute; bpm) at PRE
E (i.e. rest) aand POST (ii.e. followingg the
exerccise protocoll). * indicatees p < 0.05 between PRE
E and POST exercise.
Blood
d Lactic Accid
Blood lacctic acid was also measurred as an inddicator of exxercise intenssity. At rest
(pre),, there were no differencces (p > 0.05
5) between G
GAKIC (1.5 ± 0.7 mmol//l) and PL
(1.6 ± 0.7 mmol/ll). Following
g the exercisse protocol, B
BLa increased significanntly in both
group
ps (GAKIC = 12.8 ± 3.0 mmol/l; PL
L = 10.7 ± 2.22 mmol/l; p < 0.05 comppared to pre))
but itt was not diffferent (p > 0.05)
0
betweeen groups. (F
Figure 3)
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Figurre 3

Blo
ood Lactic Acid
A (1)

Blood
d lactic acid (mmol/l) at PRE (i.e. reest) and POS
ST (i.e. follow
wing the exeercise
proto
ocol). * indiccates p < 0.05 between PRE
P
and POS
ST exercise.
GAK
KIC vs. Placcebo
There werre no differeences betweeen GAKIC aand PL in pree-exercise bllood glucosee
conceentration (GA
AKIC = 99.4
4 ± 16.4 mg//dl; PL = 900.0 ± 7.8 mg//dl; p > 0.05). Unlike
BLa concentratio
c
on, blood glu
ucose levels were
w not siggnificantly diifferent (p > 0.05)
betweeen pre and post-exercisse. Also, therre were no siignificant diifferences inn blood
gluco
ose levels between GAK
KIC and PL following
f
thee completionn of the exerrcise protocool
(GAK
KIC= 87.6 ± 7.3 mg/dl; PL
P = 82.6 ± 8.7 mg/dl; p > 0.05). (F
Figure 4)
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Figurre 4

Blo
ood Glucosee (1)

Blood
d glucose (m
mg/dl) at PRE
E (i.e. rest) and
a POST (ii.e. followingg the exercisse protocol).
No siignificant diffferences weere detected (p > 0.05) bbetween grouups.
mental Protoocol 2
Experim
Partiicipants
This study
y consisted of
o nine healtthy, resistancce trained feemale particiipants. A
samp
ple size analy
ysis was perfformed and showed
s
that participantss were requirred to
achieeve a power of
o 0.80. Thee intra-class correlations
c
were > 0.800.
Tablee 2

Fem
male Participants Charactteristics (meean + SD)
Age (y)

Height
H
(m)

Boddy mass (kg)

Bodyy fat (%)

21.8 ± 1.0

1.62 ± 0.07

644.1 ± 14.4

22.44 ± 9.9
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1 RM and Total Load Volume
Data indicate that the 1RM was not significantly different (p > 0.05) between
GAKIC and PL. Specifically, 1RM of GAKIC was 34.1 ± 9.1 kg and 1RM of PL was
32.3 ± 8.5 kg (p < 0.05) (Figure 5A). Total load volume was calculated by multiplying
the 50% of one repetition maximum mass lifted by the sum of repetitions (i.e. six sets) to
failure. Our data showed a significant (p < 0.05) increase in TLV after GAKIC
supplementation. Specifically, GAKIC’s TLV was 1721.7 ± 479.9 kg, whereas the PL
TLV was 1479.1 ± 396.8 kg. Figure 5B illustrates the individual response of each
participant after GAKIC and PL supplementation. Importantly the TLV increased in 8 of
the 9 participants following GAKIC ingestion.
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Figurre 5

1R
RM and Totall Load Volum
me (2)

A) One repetition
n maximum (1RM) follo
owing either glycine-argiinine-α-ketooisocaproic
acid (GAKIC)
(
orr PL ingestio
on. No signifficant differeence (p > 0.005) was obseerved
betweeen GAKIC and PL. B) Total load volume
v
(TLV
V) followingg either GAK
KIC or PL
ingesstion. The TL
LV was calculated by mu
ultiplying thhe 50% of 1R
RM mass byy the sum of
repetitions perforrmed to failu
ure in six sets. * indicatees p < 0.05 between GAK
KIC and PL..
The data
d points for
fo each partiicipant are sh
hown in bothh graphs.
Hearrt Rate
Heart ratee was measured as an ind
dicator of exxercise intenssity and to ddocument thaat
particcipants in bo
oth groups ex
xerted similaar effort folloowing GAK
KIC and PL
suppllementation. At rest (pree), there weree no differennces for hearrt rate betweeen GAKIC
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and PL
P (p > 0.05)). Following
g the exercisee protocol, hheart rate inccreased signiificantly in
both groups (p < 0.05) but it was not diffferent (p > 0..05) betweenn groups (Figure 6).

Figurre 6

Heart Rate (2)

Heartt rate (beats per minute; bpm) at PRE
E (i.e. rest) aand POST (ii.e. followingg the
exerccise protocoll). * indicatees p < 0.05 between PRE
E and POST.
Blood
d Lactic Accid
Blood lacctic acid was also measurred as an inddicator of exxercise intenssity. At rest
(pre),, there were no differencces (p > 0.05
5) between G
GAKIC and P
PL. Followinng the
exerccise protocoll, blood lactiic acid increaased significcantly in bothh groups (p < 0.05) but iit
was not
n different (p > 0.05) between
b
grou
ups (Figure 7).
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Figurre 7

Blo
ood Lactic Acid
A (2)

Blood
d lactic acid (mmol/l) at PRE (i.e. reest) and POS
ST (i.e. follow
wing the exeercise
proto
ocol). * indiccates p < 0.05 between PRE
P
and POS
ST.
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CHAPTER V
DISCUSSION
The purpose of this study was to investigate the effects of GAKIC on TLV, BLa,
and heart rate during repeated bouts through a lower body resistance exercise protocol. It
was hypothesized that GAKIC supplementation would increase the total mass lifted
during repeated bouts of submaximal leg exercises in male and female participants. The
major finding of this study is that GAKIC supplementation increases lower body TLV in
both male and female groups. Following are the variables and their data points resulting
from experimental protocol 1 and experimental protocol 2.
Experimental Protocol 1
Total Load Volume
Muscular strength and endurance were measured on the lower body using the leg
press. Muscular strength was measured by using a 1RM on the leg press. Muscular
endurance was measured by using TLV, which was calculated by multiplying the 75% of
the 1RM mass by the total number of repetitions to failure. The total number of
repetitions to failure was the sum of five sets. In order to make an initial muscular
contraction, the energy source needed is adenosine triphosphate (ATP). However, ATP
only sustains about 3 seconds of maximal muscle power. For a single, maximum short
bout of muscle power, ATP is combined with cell phosphocreatine to form the
phosphagen energy system (ATP-PCr) (Guyton & Hall, 2006). In order to maintain
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maximum strength and to maintain endurance, the phosphagen energy system must
recover and resynthesize ATP quickly and efficiently. After prolonged duration of a
workout, the muscles’ phosphocreatine stores are depleted. This depletion causes the
body to switch to energy systems involving aerobic pathways (McArdle, Katch, F., &
Katch, V., 2010).
With experimental protocol 1, the major finding during our leg press exercise
protocol was that with GAKIC supplementation an increase in TLV for the lower body
was revealed. This result could be due a decrease of ammonia and the system utilized.
GAKIC supplementation may show improvements of the anaerobic system, which was
the primary energy system used for this exercise protocol.
Heart Rate
Heart rate increases linearly in direct relation to exercise intensity (Maciel, Gallo,
Marin Neto, Lima Filho, & Martins, 1986; Myers & Gullestad, 1998; Rotto & Kaufman,
1988). The heart rate measurements were used as a guide for exercise intensity for
participants in both conditions. This allowed for observing similarities in effort following
both of the treatment conditions (GAKIC and PL).
During exercise, work output, oxygen consumption, and cardiac output are
directly correlated to exercise intensity. To illustrate, muscular work output increases
oxygen consumption. The increased oxygen consumption dilates the muscle blood
vessels, which therefore increase venous return and cardiac output (Guyton & Hall,
2006). Exercise intensity is calculated by a percentage of the participant’s achieved heart
rate maximum (Lamberts & Lambert, 2009; McArdle, Katch, F., & Katch, V., 2007;
Rowell, 1988). With the participants’ mean age being 20 years of age, the calculated
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average maximum heart rate was 200 bpm. Therefore, the intensity of the TLV of the
lower body exercise protocol was moderate (71% for the GAKIC and 70% for the PL) for
both groups.
Blood Lactic Acid
Blood lactic acid was also used to indicate exercise intensity for both conditions.
Lactate continually forms during rest and moderate exercise in all individuals (Brooks,
2009; Donovan & Brooks, 1983; Hashimoto & Brooks, 2008). Lactate formation is
catalyzed by lactate dehydrogenase in a reversible reaction from pyruvate. Great
accumulations of blood lactate occur rapidly during maximal exercises lasting between
60 and 180 seconds. However, BLa accumulations do not occur at all levels of exercise.
Blood lactate production equals lactate removal and oxygen consuming reactions to
sufficiently meet the energy demands of the exercise during light to moderate exercise
(<50% of aerobic capacity). As exercise intensity increases, lactate production and lactate
accumulation increases. For aerobic metabolism, blood lactate begins to store and rise at
about 50 to 55% of the maximal capacity for healthy and untrained individuals (McArdle,
Katch, F., & Katch, V., 2010). Therefore, it is expected that as exercise intensity and
duration increases, the BLa levels should also be increased. Because there were no
significant differences in BLa levels post exercise between the GAKIC supplementation
and the PL, it can be hypothesized that GAKIC was not a lactic acid buffer.
Blood Glucose
Glucose is often referred to as “blood sugar.” During exercise, muscle cells break
down glycogen into glucose in a process called glycogenolysis. The glucose is then used
as an energy source for muscular contraction (Powers & Howley, 2007). There were no
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significant differences in blood glucose levels between pre and post-exercise, which
could be due to the large quantities of glucose that are accumulated in the glycogenstoring cells, liver and muscle cells. The exercise protocol chosen for this study made it
unlikely that there would be any significant decreases in glucose due to the duration of
the exercise bouts. Therefore, the results suggest that the GAKIC supplementation is not
a precursor for simple sugar or glucose.
Experimental Protocol 2
Total Load Volume
Muscular strength and endurance were measured on the lower body using the leg
extension. Muscular strength was measured by using a 1RM on the leg press. Muscular
endurance was measured by using TLV, which was calculated by multiplying the 50% of
the 1RM mass by the total number of repetitions to failure. The total number of
repetitions to failure was the sum of six sets.
Experimental protocol 2 major finding is that supplemental GAKIC ingestion
increases TLV during leg extension exercise. This result could be due to the increase in
phosphocreatine utilization, resulting from ammonia and clearance of substances that
decrease muscle pH levels.
Heart Rate
Heart rate increases linearly in direct relation to exercise intensity (Maciel, Gallo,
Marin Neto, Lima Filho, & Martins, 1986; Myers & Gullestad, 1998; Rotto & Kaufman,
1988). The heart rate measurements were used as a guide for exercise intensity for
participants in both conditions. This allowed for observing similarities in effort following
both conditions (GAKIC and PL).
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Exercise intensity is calculated by a percentage of the participant’s achieved heart
rate maximum (Lamberts & Lambert, 2009; McArdle, Katch, F., & Katch, V., 2007;
Rowell, 1988). With the participants’ mean age being 21 years of age, the calculated
average maximum heart rate was 199 bpm. Therefore, the intensity of the TLV of the
lower body exercise protocol was moderate (≈75% for both the GAKIC and the placebo)
for both groups.

Blood Lactic Acid
Blood lactic acid was also used to indicate exercise intensity for both conditions.
Lactate continually forms during rest and moderate exercise in all individuals (Brooks,
2009; Donovan & Brooks, 1983; Hashimoto & Brooks, 2008). Great accumulations of
BLa occur rapidly during maximal exercises lasting between 60 and 180 seconds.
However, BLa accumulations do not occur at all levels of exercise. BLa production
equals lactate removal and oxygen consuming reactions to sufficiently meet the energy
demands of the exercise during light to moderate exercise (<50% of aerobic capacity).
Therefore, it is expected that as exercise intensity and duration increases, the blood
lactate levels should also be increased. Because there were no significant differences in
BLa levels post exercise between the GAKIC supplementation and the PL, it can be
hypothesized that GAKIC was not a lactic acid buffer.
Conclusion
In conclusion, with the specific exercise protocol that was implemented in order
to demonstrate the effects of GAKIC treatment as compared to a PL treatment, it was
revealed an improvement in maximum strength in the leg press exercise and the leg
extension exercise with lower body TLV. When considering body mass and dosage of
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supplement, it was concluded in previous studies that GAKIC improvements were closely
related. With both protocols only having two testing sessions per participant separated by
one week, it gave limited observation and data collection. Further research on GAKIC’s
effects could be beneficial when conducting research over a longer period of time
allowing GAKIC to remain in the body.
Summary of Results (Experimental Protocol 1 & 2)
1) No significant difference was observed in blood lactate between GAKIC and
placebo treatments in male participants.
2) No significant difference was observed in heart rate between GAKIC and placebo
treatments in male participants.
3) A significant difference was observed in total load at 75% of IRM for five sets
between GAKIC and placebo treatments in male participants.
4) No significant difference was observed in blood glucose between GAKIC and
placebo treatments in male participants.
5) No significant difference was observed in blood lactate between GAKIC and
placebo treatments in female participants.
6) No significant difference was observed in heart rate between GAKIC and placebo
treatments in female participants.
7) No significant difference was observed in 1RM between GAKIC and placebo
treatments in female participants.
8) A significant difference was observed in total load at 50% of 1RM for six sets
between GAKIC and placebo treatments in female participants.
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Recommendations for Further Research
1) Studies should compare how supplemental GAKIC ingestion effects total load
volume during multiple exercises.
2) Studies should compare the effects of GAKIC supplementation over an 8-12 week
period.
3) A similar study should be performed comparing supplemental GAKIC ingestion
effects on trained vs. untrained participants.
4) A similar study should be performed comparing supplemental GAKIC ingestion
effects on trained participants over a longer duration of supplementation.
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Nutritional Information

OTHER

MICROCRYSTALLINE
CELLULOSE,
INGREDIENTS:
HYDROXYPROPYL CELLULOSE, COATING (POLYVINYL ALCOHOL,
POLYETHYLENE GLYCOL, HYDROXYPROPYL CELLULOSE, TITANIUM
DIOXIDE, TALC, SOY LECITHIN, POLYSORBATE 80, FD&C RED NO. 40, FD&C
YELLOW NO. 6), CROSCARMELLOSE SODIUM, STEARIC ACID, MAGNESIUM
STEARATE, SILICA, ACESULFAME-POTASSIUM.
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